ArriVent BioPharma, Inc.

Q2 2024 13F Holders

Symbol: AVBP
CUSIP: 04272N102
Type: Equity
Class: COM
Num filings: 57
Total reported value, excl. options: $405 M

Compare 2024 Q2 to

Manager	Report Date	Value ($000)	Shares	Option Type